SCHEMBL21641744

SCHEMBL21641744

CN1CCCC(n2ccc3cc(N)ccc32)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.46
NOS3 P29474 7/20 0.44
NOS1 P29475 7/20 0.44
NOS2 P35228 5/20 0.44
HTR2B P41595 1/20 0.39
TMEM97 Q5BJF2 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
GFER P55789 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HTR6 P50406 3/20 0.38
BRPF1 P55201 2/20 0.37
DRD2 P14416 1/20 0.36
SLC6A4 P31645 1/20 0.36
DGAT1 O75907 1/20 0.36
WEE1 P30291 1/20 0.36
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SCD O00767 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30271237 1.00 PRKCI (0.46) PRKCINOS3NOS1NOS2HTR2B
SCHEMBL30271234 0.92 PRKCI (0.49) PRKCINOS3NOS1NOS2KDM4E
SCHEMBL21641745 0.92 PRKCI (0.49) PRKCINOS3NOS1NOS2KDM4E
SCHEMBL12367572 0.89 NOS3 (0.54) PRKCINOS3NOS1NOS2KDM4E
SCHEMBL3355266 0.89 NOS3 (0.45) PRKCINOS3NOS1NOS2HTR2B
SCHEMBL31735587 0.86 PRKCI (0.54) PRKCINOS3NOS1NOS2KDM4E
SCHEMBL2266494 0.83 PRKCI (0.51) PRKCINOS3NOS1NOS2BRPF1
SCHEMBL30594683 0.83 PRKCI (0.51) PRKCINOS3NOS1NOS2BRPF1
SCHEMBL21671897 0.82 NOS3 (0.41) NOS3NOS1NOS2HTR2BTMEM97
SCHEMBL28192868 0.79 PRKCI (0.52) PRKCINOS3NOS1NOS2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108623615-B Macrocyclic derivatives of pyrazolo [3,4-d ] pyrimidin-3-one, pharmaceutical compositions and uses thereof 上海迪诺医药科技有限公司 2022-12-13 CN disclosed
EP-3604306-B1 MACROCYCLIC DERIVATIVE OF PYRAZOL[3,4-D]PYRIMIDIN-3-ONE, PHARMACEUTICAL COMPOSITION AND USE THEREOF SHANGHAI DE NOVO PHARMATECH CO LTD (CN) 2022-10-26 EP disclosed
US-11248006-B2 Macrocyclic derivative of pyrazol[3,4-d]pyrimidin-3-one, pharmaceutical composition and use thereof Shanghai De Novo Pharmatech Co., Ltd. (CN) 2022-02-15 US disclosed
US-20200377520-A1 MACROCYCLIC DERIVATIVE OF PYRAZOL[3,4-D]PYRIMIDIN-3-ONE, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai De Novo Pharmatech Co., Ltd. (CN) 2020-12-03 US disclosed
EP-3604306-A1 MACROCYCLIC DERIVATIVE OF PYRAZOL[3,4-D]PYRIMIDIN-3-ONE, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai de Novo Pharmatech Co., Ltd. (CN) 2020-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377520-A1 MACROCYCLIC DERIVATIVE OF PYRAZOL[3,4-D]PYRIMIDIN-3-ONE, PHARMACEUTICAL COMPOSITION AND USE THEREOF WEE1, WEE2, PDPK1 PRKCI 705/4885NOS3 1290/4885NOS1 1440/4885
US-11248006-B2 Macrocyclic derivative of pyrazol[3,4-d]pyrimidin-3-one, pharmaceutical composition and use thereof WEE1, WEE2, PDPK1 PRKCI 705/4885NOS3 1290/4885NOS1 1440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.